Background: Late-onset UC represents an important issue for the near future, but its outcomes and relative therapeutic strategies are yet poorly studied.
Aim: To better define the natural history of late-onset ulcerative colitis.
Methods: In a multicenter retrospective study, we investigated the disease presentation and course in the first 3 years in 1091 UC patients divided into 3 age-groups: diagnosis ≥65years, 40-64 years, and <40years. Disease patterns, medical and surgical therapies, and risk factors for disease outcomes were analyzed.
Results: Chronic active or relapsing disease accounts for 44% of patients with late-onset UC. Across all age-groups, these disease patterns require 3-6 times more steroids than remitting disease, but immunomodulators and, to a lesser extent, biologics are less frequently prescribed in the elderly. Advanced age, concomitant diseases and related therapies were found to be inversely associated with the use of immunomodulators or biologics, but not with surgery.
Conclusions: The conclusion that late-onset UC follows a mild course may apply only to a subset of patients. an important percentage of elderly patients present with more aggressive disease. Since steroid use and surgery rates did not differ in this subgroup, lower use of immunosuppressive therapy and biologics may reflect concerns in prescribing these therapies in the elderly.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.dld.2016.09.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
We present a case of asymptomatic non-union of distal clavicle fracture in an older adult who experienced late-onset skin dehiscence and a secondarily open fracture. We adopted a simplified surgical approach involving resection of the protruding medial clavicular fragment instead of fixation of the non-union. This approach led to the rapid healing of soft tissues while maintaining an ulcer-free status and adequate shoulder function at the one-year follow-up.
View Article and Find Full Text PDFNivolumab-Induced Immune Mediated Colitis Localized to the Distal Colon: Seven Years Into Therapy.
Cureus
October 2024
Pathology, Heartland Pathology Laboratories, Wichita, USA.
Nivolumab targets programmed cell death protein 1 (PD-1) and is used in cancer treatment by increasing the immune response. It has rarely been associated with immune-mediated colitis (IMC). We present a 66-year-old man with metastatic lung adenocarcinoma, treated with nivolumab for seven years, who developed tenesmus and mucoid bloody diarrhea.
View Article and Find Full Text PDFThe Pouch Corner: Perianal Fistulas and Ileal Pouches: Examining Fistulas Before and After Pouch Creation.
Inflamm Bowel Dis
October 2024
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
The association between primary ovarian insufficiency and increased multimorbidity in a large prospective cohort (Canadian Longitudinal Study on Aging).
Fertil Steril
August 2024
Department of Obstetrics and Gynecology, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; McMaster Institute for Research on Aging, Hamilton, Ontario, Canada; The Research Institute, St. Joseph's Healthcare, Hamilton, Ontario, Canada. Electronic address:
Objective: To describe the prevalence of multimorbidity among individuals with primary ovarian insufficiency (POI) and early menopause compared with those with the average age of menopause.
Design: Prospective cohort.
Setting: Outpatient communities across ten provinces across Canada, available from the Canadian Longitudinal Study on Aging.
Characteristics of late-onset Behçet's disease and comparison with juvenile and adult-onset Behçet's disease.
Int J Dermatol
December 2024
Department of Dermatology and Venereology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Article Synopsis
- * Out of 4,100 patients with Behçet's disease, only 4.7% had late-onset, with findings showing that symptoms and complications often developed later compared to adult and juvenile cases.
- * The research concluded that, despite some differences, LBD patients require similar follow-up care as those with adult and juvenile Behçet's disease due to comparable levels of systemic involvement over time.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!